Danaher upgraded at Goldman Sachs citing an attractive entry point

mbbirdy
Danaher (NYSE:DHR) traded higher in the premarket on Friday after Goldman Sachs upgraded the life sciences company to Buy from Neutral with a $260 per share target, citing an attractive entry point to own the stock.
The upgrade comes at